Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy
机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China.
This program was supported by the Luzhou City Science and Technology Bureau (grant number 2021LZXNYDJ10 and 2020LZXNYDJ14),
Cooperation Project between the Second People’s Hospital of Deyang and Southwest Medical University (2022DYEXNYD002).
语种:
外文
PubmedID:
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China[2]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China[2]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China.
推荐引用方式(GB/T 7714):
Feng Dechao,Wang Jie,Li Dengxiong,et al.Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy[J].Discover. Oncology.2023,14(1):155.doi:10.1007/s12672-023-00777-1.
APA:
Feng Dechao,Wang Jie,Li Dengxiong,Wu Ruicheng,Wei Wuran&Zhang Chi.(2023).Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy.Discover. Oncology,14,(1)
MLA:
Feng Dechao,et al."Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy".Discover. Oncology 14..1(2023):155